{"id":"W4386250180","doi":"10.1186/s13223-023-00820-4","title":"Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases","year":2023,"lang":"en","type":"article","venue":"Allergy Asthma and Clinical Immunology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Omalizumab; Medicine; Angioedema; Chronic urticaria; Ciclosporin; Discontinuation; Refractory (planetary science); Adverse effect; Dermatology; Tacrolimus; Medical record; Internal medicine; Chemotherapy; Immunology; Immunoglobulin E; Antibody; Transplantation","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002369389,0.0001439293,0.0005433513,0.000114997,0.00009808652,0.000004186376,0.00007812478,0.0004248357,0.000230232],"category_scores_gemma":[0.0009064514,0.0001181734,0.0002605743,0.0002032876,0.0005840941,0.00004136412,0.00009332367,0.0003413698,0.00004684173],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002682524,"about_ca_system_score_gemma":0.0002419185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009911932,"about_ca_topic_score_gemma":0.00005800318,"domain_scores_codex":[0.9983309,0.00006364702,0.000826819,0.000364377,0.00009531644,0.0003189667],"domain_scores_gemma":[0.9981027,0.001017855,0.0002001588,0.000397922,0.0001675156,0.0001137944],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02248342,0.01375975,0.0463279,0.0005522929,0.1958569,0.06022295,0.002459412,0.0001484483,0.09544567,0.226489,0.07074654,0.2655077],"study_design_scores_gemma":[0.01364216,0.01293147,0.7374474,0.000229193,0.002278371,0.006984004,0.0007161057,0.001242805,0.0007747337,0.004004515,0.2192776,0.0004716306],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925691,0.001750112,0.0001140403,0.003146336,0.0007646367,0.000329747,0.00002146882,0.0001166654,0.001187902],"genre_scores_gemma":[0.9878265,0.005123065,0.0002261837,0.0001198565,0.000301855,0.00006814185,0.0002819841,0.00002795737,0.006024476],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6911196,"threshold_uncertainty_score":0.481897,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02712979071357556,"score_gpt":0.3442398795396108,"score_spread":0.3171100888260353,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}